" /> Cyclophosphamide/Cytarabine/Intrathecal Hydrocortisone/Mercaptopurine/Intrathecal Methotrexate/Pegaspargase/Prednisone/Vincristine Regimen - CISMeF





Preferred Label : Cyclophosphamide/Cytarabine/Intrathecal Hydrocortisone/Mercaptopurine/Intrathecal Methotrexate/Pegaspargase/Prednisone/Vincristine Regimen;

NCIt synonyms : Cyclophosphamide/Cytarabine/Intrathecal Hydrocortisone/Mercaptopurine/Intrathecal Methotrexate/Pegaspargase/Prednisone/Vincristine; Cyclophosphamide-Cytarabine-Intrathecal Hydrocortisone-Mercaptopurine-Intrathecal Methotrexate-Pegaspargase-Prednisone-Vincristine; Cyclophosphamide/Cytarabine/Mercaptopurine/Pegaspargase/Prednisone/Vincristine/Hydrocortisone Intrathecal/Methotrexate Intrathecal; Cyclophosphamide/Cytarabine/Mercaptopurine/Pegaspargase/Prednisone/Vincristine/Intrathecal Hydrocortisone/Intrathecal Methotrexate;

NCIt definition : A regimen consisting of cyclophosphamide, cytarabine, intrathecal hydrocortisone, mercaptopurine, intrathecal methotrexate, pegaspargase, prednisone, and vincristine that can be used in the treatment of acute lymphoblastic leukemia (ALL).;

Details


You can consult :


Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.